[Biochemical mechanisms of action of coronarodilating agents (review of the literature)].
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000628:Aminophylline / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D002866:Chromonar / Q000494:pharmacology / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy*; D003331:Coronary Vessels / Q000187:drug effects*; D004285:Dogs; D004341:Drug Evaluation; D006801:Humans; D051379:Mice; D009243:NAD / Q000494:pharmacology / Q000627:therapeutic use; D009543:Nifedipine / Q000494:pharmacology / Q000627:therapeutic use; D005996:Nitroglycerin / Q000494:pharmacology / Q000627:therapeutic use; D010208:Papaverine / Q000494:pharmacology / Q000627:therapeutic use; D010276:Parasympatholytics / Q000494:pharmacology / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D010276:Parasympatholytics; D014665:Vasodilator Agents; D009243:NAD; D000628:Aminophylline; D014700:Verapamil; D010208:Papaverine; D005996:Nitroglycerin; D009543:Nifedipine; D002866:Chromonar
Biokhimicheskie mekhanizmy deĭstviia koronarorasshiriaiushchikh sredstv